Spark Biomedical News

Press Releases

Battelle and Spark Biomedical join forces to advance bioelectric treatment solutions for opioid use disorderRead MoreRead More
NOWS Clinical Trial Phase IIRead MoreRead More
Long-Term Addiction Clinical TrialRead MoreRead More
Spark Biomedical, Inc Enlists Expertise of Eric Hargan and The Hargan GroupRead MoreRead More
Sierra Tucson Combats Opioid Withdrawal Using Groundbreaking Wearable Neurostimulation TherapyRead MoreRead More
Bux Pain Management Treats First Commercial Patient in the Nation Using Spark Biomedical’s Sparrow Therapy SystemRead MoreRead More
Spark Biomedical’s Sparrow Therapy System™ receives FDA Clearance for Opioid Withdrawal Relief in AdultsRead MoreRead More
Spark Biomedical Receives FDA Breakthrough Device Designation for Infant Transcutaneous Auricular Neurostimulation (tAN™) Device, The Roo™ SystemRead MoreRead More
Nine of the Foremost Pain Management Physicians Join the Spark Biomedical, Inc. Medical Advisory BoardRead MoreRead More
Spark Biomedical Receives $217K NIH Grant to Help Opioid-Addicted NewbornsRead MoreRead More